BSEContinental Chemicals Ltd· IT - SoftwareHighNeutral
Announced Mon, 22 Sept, 2025 · 16:51 IST

AS PER THE FILE ATTACHED

Promoter Family Board EntryManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
₹69.40
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%—
Software Products peers, median of 35sector-0.0%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.3—+0.0—
Next day
—-0.6—-0.0—
2d
+0.0-1.7+1.7-0.4+0.4
3d
—-3.8—-2.0—
4d
—-4.6—-4.1—
5d
—-5.0—-2.2—
1w
—-2.4—-0.7—
15d
+2.2-3.0+5.2+1.6+0.6
1m
—-1.4—+2.4—
2m
—-4.9—-4.1—
3m
—-5.9—-6.9—
UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 35Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At its 40th Annual General Meeting held on September 20, 2025, shareholders of Continental Chemicals Ltd approved three key items. First, B.S. Goyal & Co was appointed as the company's Secretarial Auditor for a five-year term covering FY2025-26 through FY2029-30. Second, Mr. Naresh Kumar Chibba (DIN: 00376963) was reappointed as Managing Director for a two-year term effective August 1, 2026; he has been managing the company since its incorporation and holds 1,33,110 shares (5.92% stake). Third, Ms. Parul Suraiya (DIN: 08490663) was appointed as an Independent Director for five years till September 19, 2030; she brings experience in hotel and guest service management and holds no shares in the company.

Likely market impact

Continuity at the top with the founder-promoter MD getting another term should reassure shareholders, while the addition of a new Independent Director strengthens board composition. The reappointment of the MD alongside his children already on the board highlights the company's promoter-family driven governance structure, which investors may view as a governance consideration.